Skip to main content
GENEDRIVE PLC logo

GENEDRIVE PLC — Investor Relations & Filings

Ticker · GDR ISIN · GB00B1VKB244 LEI · 213800ZYODIRZ87Y4K14 IL Manufacturing
Open in API
Filings indexed 606 across all filing types
Latest filing 2021-12-30 AGM Information
Country GB United Kingdom
Listing IL GDR

About GENEDRIVE PLC

https://genedriveplc.com/

Genedrive PLC is a molecular diagnostics company specializing in the development and commercialization of a rapid, point-of-care pharmacogenetic testing platform. The company's core technology, the Genedrive® System, is designed for the swift diagnosis of genetic variants to enable personalized medicine in critical care settings. Its key products include the Genedrive® MT-RNR1 ID Kit, used to prevent antibiotic-induced hearing loss in infants, and the Genedrive® CYP2C19 ID Kit, which helps optimize antiplatelet therapy for stroke patients. The platform empowers clinicians to make safer and more effective treatment decisions by providing crucial genetic information at the point of need, thereby improving patient outcomes.

Recent filings

Filing Released Lang Actions
Result of AGM
AGM Information Classification · 1% confidence The document explicitly states it is announcing the 'Result of AGM' (Annual General Meeting). It provides a detailed table showing the proxy voting results for all resolutions proposed at the meeting. This directly aligns with the definition of AGM Information (AGM-R), which covers presentations and materials shared during the AGM, and specifically includes the results of shareholder votes, which is the core content here. Although DVA (Declaration of Voting Results) is also relevant, AGM-R is the broader category for materials related to the meeting itself, and the context strongly points to the AGM proceedings.
2021-12-30 English
Second Price Monitoring Extn
Regulatory Filings Classification · 1% confidence The document is very short (1931 characters) and contains the header 'RNS Number'. It describes a 'Second Price Monitoring Extension' related to trading activity on the London Stock Exchange. The text explicitly states, 'This information is provided by RNS, the news service of the London Stock Exchange.' This indicates it is a general regulatory announcement disseminated via the RNS system, rather than a specific financial report like an ER, 10-K, or IR. Since it is a general regulatory announcement that doesn't fit the other specific categories (like DIRS, DIV, or MANG), the most appropriate classification is the general regulatory filing fallback category.
2021-12-30 English
Price Monitoring Extension
Regulatory Filings Classification · 1% confidence The document is very short (1914 characters) and contains the header 'RNS Number : 0492X' and mentions 'RNS, the news service of the London Stock Exchange'. The content itself is a brief announcement regarding a 'Price Monitoring Extension' for a security, which is a specific operational notice related to trading rather than a comprehensive financial report or a standard regulatory filing like 10-K or ER. Since it is a general regulatory announcement distributed via the RNS system and does not fit into the more specific categories (like DIV, DIRS, ER, etc.), the most appropriate classification is the general Regulatory Filings category (RNS).
2021-12-30 English
Second Price Monitoring Extn
Regulatory Filings Classification · 1% confidence The document is very short (1931 characters) and contains the header 'RNS Number : 5045W'. It announces a 'Second Price Monitoring Extension' related to trading activity on the London Stock Exchange. The text explicitly states, 'This information is provided by RNS, the news service of the London Stock Exchange.' This indicates it is a general regulatory announcement disseminated via the RNS system, rather than a specific financial report like an ER, 10-K, or IR. Since it is a general regulatory announcement that doesn't fit the specific categories (like DIRS, DIV, or DLST), the most appropriate fallback category is Regulatory Filings (RNS).
2021-12-22 English
Price Monitoring Extension
Regulatory Filings Classification · 1% confidence The document is very short (1914 characters) and contains the header 'RNS Number : 5031W' and mentions 'RNS, the news service of the London Stock Exchange'. The content describes a 'Price Monitoring Extension' for a security, which is a specific, brief operational announcement related to trading. This type of short, specific regulatory update that doesn't fit into major reporting categories (like 10-K, ER, IR) is best classified as a general Regulatory Filing (RNS), as per the definition and the presence of the RNS identifier.
2021-12-22 English
UK CTDA application for Genedrive® COV19-ID kit
Regulatory Filings Classification · 1% confidence The document begins with 'RNS Number : 4160W' and contains standard regulatory boilerplate language at the end, including references to RNS and the London Stock Exchange. The content announces a specific corporate action/update: the filing for approval under UK CTDA regulations for their COVID-19 test kit, including performance data. This is a typical regulatory announcement disseminated via the RNS system. Since it is not a full report (like 10-K or IR), nor a specific announcement like a dividend (DIV) or management change (MANG), it fits best under the general 'Regulatory Filings' category (RNS) as a miscellaneous regulatory update, although it is highly specific. Given the context of RNS distribution, RNS is the most appropriate code for this type of market news release.
2021-12-22 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.